President von der Leyen announced an additional €40 million Global Gateway investment in the development of a vibrant biopharmaceutical industry and local manufacturing of vaccines, medicines and health products in Rwanda, which was welcomed by President Kagame.
The funds will benefit particularly higher, technical and vocational education and training, research and development, entrepreneurship, and supply chains.
With the investment announced today, Team Europe’s support to local manufacturing and access to vaccines, medicines and health technologies in Rwanda amounts to approximately €94 million.
Rwanda and the European Union strengthen partnership (europa.eu)